National Vision Holdings, Inc. (EYE): EBITDA
$149.98M
Year ended 2026-01-03, Fiscal 2025
$175.10M
Trailing 12 months to 2026-07-04
+2.0%
3-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2026-01-03, Fiscal 2025 | $149.98M | +85.2% | 2026-03-04, From 2024-12-29 |
| 2024-12-28 | $80.99M | -29.2% | 2026-03-04, From 2023-12-31 |
| 2023-12-30 | $114.36M | -19.2% | 2026-03-04, From 2023-01-01 |
| 2022-12-31 | $141.46M | n/c | 2025-02-26, From 2022-01-02 |
| 2022-01-01, Fiscal 2021 | $272.03M | +52.3% | 2024-02-27, From 2021-01-03 |
| 2021-01-02, Fiscal 2020 | $178.59M | +11.1% | 2023-03-01, From 2019-12-29 |
| 2019-12-28 | $160.82M | +37.8% | 2022-02-28, From 2018-12-30 |
| 2018-12-29 | $116.69M | -7.6% | 2021-03-03, From 2017-12-31 |
| 2017-12-30 | $126.27M | +8.2% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $116.75M | n/c | 2019-02-27, From 2016-01-03 |
| 2016-01-02, Fiscal 2015 | $88.75M | n/a | 2018-03-08, From 2015-01-04 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $149.98M | +85.2% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $1.06B | -1.9% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $44.94M | +185.3% |
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $534.00M | -10.7% |
| RxSight, Inc. (RXST) | 2025-12-31 | -$44.92M | n/m |
Compare EYE, COO, WRBY, BLCO side by side · Screen every company in Ophthalmic Goods ↗